Chinese Medicine vs Western Treatments - A Balanced Comparison (2026)
By Ava Huang, Herbal Science Researcher at QICAOGANGMU | Updated: May 2026 | Reading time: 9 minutes
Psoriasis is a chronic autoimmune condition causing the skin to regenerate too rapidly, producing raised red plaques with silvery scaling. It affects around 2-3% of the global population - approximately 125 million people. While modern medicine offers a broad treatment spectrum, Traditional Chinese Medicine presents a complementary approach with a distinct mechanistic logic. This article compares the two frameworks honestly: their mechanisms, evidence quality, side effect profiles, and where topical herbal treatment like QICAOGANGMU fits alongside medical care.
Where QICAOGANGMU fits: Psoriasis is driven by IL-17/IL-23 pathway dysregulation and keratinocyte hyperproliferation - mechanisms that systemic biologics address most powerfully. QICAOGANGMU provides topical anti-inflammatory (NF-kB via Ku Shen), itch relief (TRPV3 via She Chuang Zi, TRPM8 via Menthol), and Staph protection (Stemonae Radix) without steroids. It is most suited for daily maintenance, plaque itch and redness management, and steroid-sparing - not as a standalone treatment for moderate-to-severe psoriasis. PMID 38358770
Quick reference: TCM vs Western approaches to psoriasis
| Aspect | Western medicine | Traditional Chinese Medicine |
|---|---|---|
| Disease model | Autoimmune - Th17/IL-23 pathway dysregulation, keratinocyte hyperproliferation | Blood Heat, Wind-Dampness, or Blood Stasis patterns causing skin imbalance |
| Primary treatments | Topical steroids, vitamin D analogues, phototherapy, biologics (anti-IL-17/IL-23) | Herbal topicals and internal formulas, acupuncture, dietary modification |
| Evidence strength | Strong RCT evidence for biologics and phototherapy; long-term steroid risks documented | Growing preclinical evidence; fewer large RCTs; indigo naturalis has clinical trial data |
| Topical side effects | Skin atrophy, tachyphylaxis, rebound with steroids; vitamin D analogues generally well-tolerated | Low risk topically; systemic herbal treatments have separate risk profile |
| Suitability for daily use | Steroids: restricted duration; vitamin D analogues and emollients: suitable; biologics: injections | Topical herbal creams: suitable for continuous daily use without duration ceiling |
What is psoriasis? Pathophysiology
Psoriasis is a chronic, relapsing immune-mediated skin condition driven by Th17 T-cell activation and IL-23/IL-17 cytokine signalling. This inflammatory cascade triggers keratinocyte hyperproliferation - skin cells turn over in 3-5 days rather than the normal 28-30 days, producing the characteristic thickened plaques with silvery scale. PMID 30909615
Common presentations include raised red plaques on the elbows, knees, scalp, and lower back. Associated features include:
- Red plaques with white or silver scaling
- Dry, cracked skin that may bleed at scale margins
- Itch and burning sensation
- Nail changes: pitting, onycholysis, subungual hyperkeratosis
- Psoriatic arthritis in approximately 30% of patients PMID 33812489
Triggers
Psoriasis flares are triggered by stress, streptococcal infection, certain medications (lithium, beta-blockers, antimalarials), skin trauma (Koebner phenomenon), alcohol, and smoking. Understanding personal triggers is an important part of long-term management alongside treatment.
Western medicine approaches to psoriasis
Topical treatments (mild to moderate psoriasis)
- Topical corticosteroids - effective short-term anti-inflammatory for plaque management. Risk profile with long-term use includes skin atrophy, tachyphylaxis (diminishing effect), and rebound on stopping. PMID 25862024
- Vitamin D analogues (calcipotriol, calcitriol) - inhibit keratinocyte proliferation and modulate T-cell activity. Generally well-tolerated. Often used in combination with topical steroids to reduce steroid requirements. PMID 17935517
- Calcineurin inhibitors (tacrolimus, pimecrolimus) - steroid-sparing options for facial and intertriginous psoriasis where steroids carry the highest atrophy risk. PMID 15523350
Phototherapy (moderate psoriasis)
Narrowband UVB phototherapy is effective for widespread plaque psoriasis and is considered a first-line systemic-equivalent treatment. It reduces T-cell activation and normalises keratinocyte proliferation. Requires clinical sessions 2-3 times weekly and is not suitable for everyone.
Systemic treatments (moderate to severe psoriasis)
- Methotrexate - effective immunosuppressant; hepatotoxicity (liver toxicity) risk with long-term use requires regular monitoring
- Acitretin - oral retinoid; teratogenic and requires strict contraception; liver function monitoring required
- Biologics (anti-IL-17, anti-IL-23, anti-TNF) - most effective treatments for moderate-severe psoriasis; adalimumab, secukinumab, ixekizumab, risankizumab. Require injection or infusion. PMID 32189327
Important: Liver toxicity is a documented risk of systemic psoriasis treatments (methotrexate, acitretin) - not of topical treatments. Topical steroids, vitamin D analogues, and topical herbal creams do not carry hepatotoxicity risk. When comparing topical and systemic treatments, these side effect profiles should not be conflated.
The TCM approach to psoriasis
In TCM, psoriasis is understood through pattern differentiation rather than a single disease model. Common patterns include:
- Blood Heat - active, spreading plaques with intense redness; treated by cooling and detoxifying the Blood
- Blood Stasis - chronic, thick, purplish plaques; treated by invigorating Blood circulation
- Blood Dryness - dry, scaly plaques, often in older patients or chronic disease; treated by nourishing Blood and moistening
- Wind-Dampness - itchy, weeping, or flexural involvement; treated by dispelling Wind and transforming Dampness
TCM treatment combines internal herbal formulas (targeting systemic patterns), topical applications (for local plaque management), dietary modification, and acupuncture. The most clinically studied TCM approach for psoriasis is indigo naturalis (Qing Dai), which has RCT evidence for plaque psoriasis specifically. PMID 17341866
QICAOGANGMU - daily topical support for psoriasis-affected skin
NF-kB anti-inflammatory (Ku Shen 1.5%), TRPV3 itch relief (She Chuang Zi 3%), deep penetration (Borneolum 2%), Staph protection (Stemonae Radix 0.5%), TRPM8 cooling (Menthol 0.5%). No steroids. No skin thinning. No rebound. Suitable as daily maintenance alongside prescribed treatment.
Shop QICAOGANGMU Herbal Cream →QICAOGANGMU's five herbs and their relevance to psoriasis
QICAOGANGMU Caoben Yijun Rugao addresses the topical inflammatory and itch components of psoriasis through five complementary mechanisms:
| Herb | TCM function | Pharmacological relevance to psoriasis | Evidence |
|---|---|---|---|
| 苦参 Ku Shen (Sophora flavescens) 1.5% | Clears Heat, dries Dampness, stops itch | NF-kB inhibition and Th2 cytokine suppression; anti-inflammatory activity in psoriasiform lesion models | PMID 38358770 |
| 蛇床子 She Chuang Zi (Cnidium monnieri) 3% | Expels Wind, dries Dampness, stops itch | TRPV3 itch receptor inhibition; addresses non-histaminergic itch of psoriasis plaques | PMID 30108138 |
| 冰片 Bing Pian (Borneolum Syntheticum) 2% | Opens pores, guides herbs deep, cools | Penetration enhancer driving actives into thick psoriatic plaques; TRPA1/TRPM8 itch relief | PMC5452010 |
| 百部 Bai Bu (Stemonae Radix) 0.5% | Kills parasites, moistens Lung, dispels Wind | Staph aureus antibacterial; COX-2/NO anti-inflammatory - addresses secondary bacterial burden on psoriatic skin | PMID 35295975 |
| 薄荷脑 Bo He Nao (Menthol) 0.5% | Disperses Heat, cools, relieves itch | TRPM8 cold receptor activation within minutes - immediate itch and burning relief on plaques | PMID 30067875 |
How to use QICAOGANGMU for psoriasis
- Wash with plain warm water only - no soap or cleanser on psoriatic plaques. Pat gently dry. Avoid hot water and vigorous rubbing on plaque surfaces.
- Apply a thin layer to plaques and surrounding skin - Borneolum drives all actives through even thick psoriatic scale. Do not apply to cracked, bleeding, or weeping plaque surfaces.
- Apply 2-3 times daily during active flares. Once daily for maintenance on stable plaques.
- Patch test first - mandatory 24-48 hours on the inner forearm before first widespread use.
Frequently asked questions
Can QICAOGANGMU cure psoriasis?
No. Psoriasis has no known cure. QICAOGANGMU helps manage topical symptoms - itch, redness, and inflammation - as part of an ongoing management approach. It does not address the systemic IL-17/IL-23 immune pathway that drives psoriasis, which requires medical treatment for moderate-to-severe disease.
Is it safe to use alongside my current psoriasis medication?
Yes in most cases, with one timing note: apply QICAOGANGMU first, allow 5 minutes to absorb, then apply any prescribed topical (steroid, vitamin D analogue). Always inform your dermatologist of all products applied to psoriatic skin. Do not apply to skin that is currently being treated with phototherapy immediately before a session.
Is QICAOGANGMU suitable for psoriasis on the face and scalp?
QICAOGANGMU can be used on facial psoriasis where it carries no atrophy risk - unlike topical steroids, which should be used with caution on the face. For scalp psoriasis specifically, application to the scalp skin (not hair) is possible but a dedicated scalp preparation may be more practical. See our article on scalp conditions and QICAOGANGMU.
How does QICAOGANGMU differ from steroid creams for psoriasis?
Topical steroids produce faster initial plaque clearance but cannot be used continuously due to skin atrophy and tachyphylaxis risks. QICAOGANGMU provides sustained anti-inflammatory and antipruritic support without a duration ceiling, making it suitable for daily long-term maintenance that steroids cannot provide. See our full comparison: QICAOGANGMU vs steroid creams.
QICAOGANGMU - herbal topical support for psoriasis management
Five-herb TCM formula covering inflammation, itch, and bacterial protection. No steroids. No skin thinning. No rebound. Suitable alongside prescribed treatment for daily maintenance. Verified steroid-free. Ships worldwide.
"My psoriasis plaques were manageable but the itch was unbearable between steroid applications. QICAOGANGMU has filled that gap - I use it daily and the itch is under control."
- Verified Customer, March 2026
"I use QICAOGANGMU on my facial psoriasis where I can't use steroids. No atrophy risk, just consistent itch and redness relief."
- Verified Customer, January 2026
We offer a 100-day money-back guarantee. Try QICAOGANGMU risk-free.
Related articles
- Psoriasis: Causes, Symptoms and Natural Treatment Guide
- QICAOGANGMU vs Steroid Creams: Full Mechanism and Safety Comparison
- Herbal Remedies for Psoriasis: How QICAOGANGMU Aligns with TCM
Clinical references
- Rendon A, Schakel K. Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences. 2019;20(6):1475. PMID 30909615
- Griffiths CEM et al. Psoriasis. Lancet. 2021;397(10281):1301-1315. PMID 33812489
- Pan YJ et al. Anti-inflammatory activity of flavonoids and alkaloids from Sophora flavescens. Phytotherapy Research. 2024;38(4):1951-1970. PMID 38358770
- Sun X-Y et al. Antipruritic effect of osthole through selective TRPV3 inhibition. International Journal of Molecular Sciences. 2018;19(10):3007. PMID 30108138
- Dai H et al. Topical borneol-induced analgesia and enhanced transdermal delivery. Experimental and Therapeutic Medicine. 2017;13(6):3267-3272. PMC5452010
- Xu Y et al. Alkaloids from Stemona tuberosa and their anti-inflammatory activity. Frontiers in Chemistry. 2022;10:847595. PMID 35295975
- Misery L et al. Anti-itching effects of a TRPM8 agonist cream in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2019;33(2):e67-e69. PMID 30067875
- Barnes L, Kaya G, Rollason V. Topical corticosteroid-induced skin atrophy. Drug Safety. 2015;38(5):493-509. PMID 25862024
- Lin YK et al. Indigo naturalis topical for plaque psoriasis. British Journal of Dermatology. 2007;156(1):100-106. PMID 17341866
- Liao YH et al. Calcitriol vs tacrolimus in facial and intertriginous psoriasis. British Journal of Dermatology. 2007;157(1):50-56. PMID 17935517
- Lebwohl M et al. Tacrolimus ointment for facial and intertriginous psoriasis. Journal of the American Academy of Dermatology. 2004;51(5):723-730. PMID 15523350
- Smith CH et al. BAD guidelines biologic therapy psoriasis. British Journal of Dermatology. 2020;182(3):785-786. PMID 32189327
© 2026 QICAOGANGMU. All rights reserved.